%0 Journal Article
%A Slamon, D J
%A Neven, P
%A Chia, S
%A Jerusalem, G
%A De Laurentiis, M
%A Im, S
%A Petrakova, K
%A Valeria Bianchi, G
%A Martín, M
%A Nusch, A
%A Sonke, G S
%A De la Cruz-Merino, L
%A Beck, J T
%A Ji, Y
%A Wang, C
%A Deore, U
%A Chakravartty, A
%A Zarate, J P
%A Taran, T
%A Fasching, P A
%T Corrigendum to 'Ribociclib plus fulvestrant for postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in the phase III randomized MONALEESA-3 trial: updated overall survival': [Annals of Oncology Volume 32, Issue 8, August 2021, Pages 1015-1024].
%D 2021
%U https://hdl.handle.net/10668/27558
%~